As the COO of Bariendo, Chuck Dinolfo stands at the forefront of EndoBariatric innovation and progress. He has established the three most significant EndoBariatric programs in the United States and was pivotal in pioneering the world’s first OverStitch procedure with GEN1 and the inaugural OverStitch Sx procedure. Chuck’s reputation as a seasoned executive is underscored by his ability to foster growth in organizations and his extensive experience collaborating with cross-functional teams on strategic planning, sales, IDN’s, market development, and beyond.

His acumen extends to areas like analytics, marketing, contract negotiation, and educational and engineering program management. Furthermore, Chuck is highly skilled in competitive business conversion and adept at employing protective and defensive strategies. In terms of specialties, Chuck is renowned for his prowess in Medical Device Sales, Marketing, and Leadership, particularly within the OR and GI selling environments. His surgical expertise spans a diverse range, from Plastics and Cardio-Thoracic to Bariatric, Urology, IT, and ENT.